Figure 5.

Statistical analysis of the differences in programmed death (PD)‐1‐positive tumor‐infiltrating immune cell (TIIC) score at the tumor nest (A) and the tumor periphery (B), and PD‐ligand (PD‐L1) at tumor nest (C), tumor periphery (D) and PD‐L1 tumor score (E) in clear cell renal cell carcinoma tissues with or without VEGF‐TKI vascular endothelial growth factor‐tyrosine kinase inhibitor treatment. Bars: indicate mean